Outlook Therapeutics, Inc.OTLKNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank75
3Y CAGR+217.6%
5Y CAGR+40.1%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+217.6%/yr
vs -79.2%/yr prior
5Y CAGR
+40.1%/yr
Recent acceleration
Acceleration
+296.8pp
Accelerating
Percentile
P75
Within normal range
vs 5Y Ago
5.4x
Strong expansion
Streak
3 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $1.42M | +87.1% |
| 2025 | $756330.00 | +564.3% |
| 2024 | $113859.00 | +157.7% |
| 2023 | $44188.00 | -78.4% |
| 2022 | $204694.00 | -21.9% |
| 2021 | $262139.00 | -52.7% |
| 2020 | $554069.00 | -97.7% |
| 2019 | $23.80M | +28.6% |
| 2018 | $18.50M | -22.3% |
| 2017 | $23.81M | - |